Related topics

GenMark Diagnostics: 2Q Earnings Snapshot

July 30, 2018

CARLSBAD, Calif. (AP) _ GenMark Diagnostics Inc. (GNMK) on Monday reported a loss of $16.5 million in its second quarter.

The Carlsbad, California-based company said it had a loss of 30 cents per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 21 cents per share.

The molecular diagnostics company posted revenue of $14.9 million in the period, exceeding Street forecasts. Three analysts surveyed by Zacks expected $14.7 million.

GenMark Diagnostics expects full-year revenue in the range of $68 million to $72 million.

GenMark Diagnostics shares have climbed 45 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $6.04, a decrease of 49 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GNMK at https://www.zacks.com/ap/GNMK

Update hourly